Matthew Wongchenko

Matthew Wongchenko

Company: Genentech

Job title: Principal Scientific Manager


Exploiting Biomarkers for A Personalized Healthcare Approach to the Development of Ipatasertib 2:00 pm

Advancing understanding of alterations of the PI3K/AKT pathway in human cancer and the differences in frequencies of alterations in different cancer types Determining the role of PI3K/AKT activation in adaptive resistance in current treatment standards to inform future resistance strategies Developing flexible patient selection strategies based on disease and combination context to overcome resistanceRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.